Search Results 851-860 of 25320 for Pulmonary
Participates will be in a 1:1 allocation to treatment with the Airiver Pulmonary DCB or standard of care laryngoscopic/bronchoscopic balloon dilation, ...
Lecturer of the Month, Pulmonary Nodules and Lung CancerPulmonary Medicine Residency Program, Division of Pulmonary Medicine, Department of Internal Medicine.
The purpose of this study is to evaluate the effectiveness, safety, and pharmacokinetics of PRM-151 compared with placebo in patients with idiopathic pulmonary ...
The secondary outcome is to assess the impact of pulmonary arterial hypertension on healthy lifestyle of the patients. Participation eligibility. Participant ...
e, Pulmonary hypertension, Pulmonary fibrosis, Cystic fibrosis, Bronchiectasis, Sarcoidosis, Pulmonary valve disease, Advanced lung disease. Show more areas ...
Cyril Varghese is a Consultant in the Department of Critical Medicine and Division of Pulmonary Medicine at Mayo Clinic in Arizona, and also an adjunct faculty ...
He obtained fellowship subspecialty training in pulmonary and critical care at the Duke University School of Medicine. He has also completed a Master of Science ...
Pulmonary vascular complications of liver disease. Dr. DuBrock is interested in pathophysiology, diagnosis and management of portopulmonary hypertension and ...
Education · 1994. Fellow - Pulmonary and Critical Care MedicineUniversity of Pittsburgh Medical Center · 1990. Resident - Internal MedicineUniversity of ...
Screening for lung cancer · Diagnosis and staging of lung cancer · Bronchoscopy and interventional pulmonology · Evaluation of pulmonary nodules · Pleural diseases ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.